Scaling CRM Transformation in Life Sciences Through Governance & Behavior Change
For most life sciences organizations, the next CRM isn’t just a system swap. It’s a wholesale reset of how commercial, medical and field teams engage healthcare professionals (HCPs), orchestrate content, capture safety signals and prepare for AI-enabled engagement. A CRM implementation (or migration) is high stakes in any industry; in life sciences, it’s existential.
Despite this recognition, large-scale transformations like a CRM rollout still fail or under-deliver at alarming rates. According to a 2024 Project Management Institute study, less than half of transformation projects are seen as clear successes — with just over half (52%) landing in “mixed” or “failure” territory. Forrester research suggests only about a third of transformation efforts ever fully reach their desired outcomes. When that happens, organizations don’t just miss business targets — they erode trust in leadership, fuel change fatigue and make people more skeptical of the next initiative.
Behind these statistics are familiar root causes: complex stakeholder landscapes, conflicting priorities, overstretched managers and communication that never quite connects with how work actually gets done. It's why a structured change approach with active executive sponsorship and consistent communication is so important. Longitudinal research from Prosci finds initiatives with strong change management are six to seven times more likely to meet or exceed objectives than those without.
The message: the success of your CRM migration will stand or fall on change management, not configuration. This blog lays out a practical change playbook tailored to life sciences CRM programs as the industry anticipates a new era of engagement.
The POV: Global Consistency, Local Tailoring, Persona-Specific Change
In life sciences, you’re not simply rolling out a new tool; you’re rewiring compliant workflows for samples, safety reporting and medical information. You’re also reshaping how reps, medical science liaisons (MSLs), key account teams and medical colleagues operate day to day, while tightening connections between global, regional and local teams. Ultimately, you’re laying the data and behavior foundation required for credible AI agents and truly omnichannel engagement.
The only success path is to pair global consistency in controls and data with thoughtful local tailoring and persona-specific behavior change, all reinforced through continuous feedback and strong governance.
Anything short of this balance leads to failure in one of two ways: 1) fragmentation, where every country reverts to its own rules and workarounds, or 2) paralysis, where change stalls amid endless attempts to force global alignment in areas that don’t truly need it. In both cases, resistance hardens — because the program is perceived as an isolated “IT project” rather than a business imperative that provides clear direction while still leaving room for local autonomy and ownership. As we’ll explore later, that calibrated flexibility is critical to navigating the people side of change.
Why CRM Change in Life Sciences is Uniquely Challenging
We’ve already introduced the complexity that comes with multi-geo, multi-org structures, but several other factors make life sciences CRM and engagement platforms different from generic sales tech:
- Good x Practice (GxP), Pharmacovigilance (PV) & Data Privacy: Core processes— such as adverse event (AE) capture, medical inquiries, consent management and controls aligned to 21 CFR Part 11, GDPR, LGPD and local regulations— must be preserved or strengthened during migration, not deferred as something to “fix later.”
- Persona Diversity: Field reps, MSLs, key account teams, medical information specialists, patient support, contact centers and commercial operations all depend on (and contribute to) the same engagement backbone, requiring a platform that can support diverse needs without fragmenting.
- AI & Data Ambitions: Unified HCP/HCO profiles, next-best engagement strategies and AI agents embedded in workflows can only deliver value when the underlying data is clean, consistent and captured through standardized, widely adopted processes.
Taken together, these realities make CRM transformation in life sciences less about swapping tools — and more about redesigning a compliant, multi-persona engagement engine that can actually support the outcomes you’re aiming for.
Set an Outcome, People & Culture-Focused ‘North Star’
A common failure pattern: defining the program as “migrating off platform X” instead of “modernizing how we engage customers.” In some ways, the digital transformation isn’t about the technology at all.
High-performing programs start by articulating a business “North Star.” For example:
- 30% improvement in HCP satisfaction with digital and in-person engagement
- 25% reduction in redundant processes for reps and MSLs
- 20% faster decision cycles and approvals
- Fewer compliance incidents and cleaner adverse event (AE) / consent capture
Coupled with a clear articulation of “why now” (e.g. contract shifts, legacy platform risk, AI-enablement), these outcomes become the backbone of your change narrative. At the same time, your key points must create the emotional pull needed to mobilize the people who must make it real. Metrics matter — but they don’t automatically translate into desire, commitment or day-to-day behavior change across teams.
An even stronger platform is a future-state vision that’s outcomes-based and people-centered: grounded in what customers will experience differently and what employees will be able to do better, faster and with less friction. When individuals can see themselves in the story — how their work improves, how decisions get easier, how collaboration becomes more effective — the case for change becomes personal rather than abstract. To accelerate a culture shift, the vision should also capture your AI ambition: not as a technology tagline, but as a clear aspiration for how AI will augment roles, elevate judgment and unlock new ways of working that employees can rally around.
Institute Multi-Level Governance
A well-structured, multi-level governance model ensures global consistency, local flexibility, compliance and the long-term scalability of your desired outcomes. This framework is especially critical in life sciences where medical information (MI), consent and promotional compliance requirements differ by region, but must follow global standards.
Strategic Layer:
Focuses on long-term vision, enterprise-wide alignment and prioritization of initiatives. Ensures the platform supports overarching business goals and compliance with global standards.
Ex. Defines the global CRM strategy, roadmap, template and data model — establishing modules that must be global (MI, consent, AE), while remaining sensitive to local legal and compliance regulations.
Program Leadership Council:
Acts as the bridge between strategy and execution, overseeing program-level decisions, resource allocation and cross-functional collaboration. A Change Control Board (CCB) that ensures alignment between business units, regions and technical teams.
Ex. Oversees impact assessments — evaluating and approving market and brand-specific change requests and potential edits to the global template.
Delivery Layer:
Handles day-to-day execution and maintenance — including configuration, development and deployment. Ensures solutions meet business requirements while adhering to governance policies and scalability standards.
Ex. Configures and tests key CRM workflows, such as calls, samples, AE/MI and consent capture, key account planning and omnichannel journeys — ensuring rollouts are aligned with the standards set by previous levels.
While multi-level governance (MLG) defines the decision rights, standards and controls, organizational change management (OCM) makes those decisions real for people across markets. It aligns leaders, prepares stakeholders, tailors messaging to each persona and reinforces new behaviors through training, coaching and continuous feedback. Together, MLG safeguards global consistency while OCM drives local understanding, buy-in and sustained usage — preventing the classic failure modes.
Design Persona-Based Change, Not Generic Comms
With governance and change management tightly linked, the next question is how to execute OCM in a way that matches how people in life sciences actually work — and that starts with persona-based change. A life sciences CRM program isn’t changing just one audience, it’s simultaneously reshaping how field reps and key account managers engage customers, how MSLs and medical affairs collaborate, and how operations, compliance, medical information and support teams coordinate behind the scenes. Each group has different responsibilities, constraints and definitions of success (including motivations, mindsets and incentives), so a one-size-fits-all communication and training approach will never land.
Instead, the change strategy should be persona-led. That means using stakeholder mapping and impact assessments to understand what the shift really means for each group, then building tailored communications, role-specific enablement paths and targeted support around those needs.
The mantra: meet each persona where they are, explain what will be different and why it matters and equip them with the tools and guidance to adopt the new way of working with confidence. In practice, that means:
Different messages…
Reps: “Less admin, cleaner calls, smarter targeting.”
MSLs: “Better scientific engagement history, integrated insights, less duplication.”
Compliance/PV: “Stronger controls, better audit trails, fewer findings.”
Different enablement methods…
Reps: In-the-flow guidance, job aids and quick coaching tied to call planning.
MSLs: Scenario-based training aligned to scientific exchange workflows.
Compliance/PV: Role-based training anchored in real end-to-end workflows (e.g. samples, medical inquiries, omnichannel journeys, content approvals).
Different proof points…
Reps: Early demos using their data and scenarios.
MSLs: Champions recruited from their peer group.
Compliance/PV: Audit-ready evidence packs generated from the system.
While change is often framed at the organizational level, success ultimately depends on guiding individuals through new ways of working. Real adoption happens one person at a time.
If you’re a life sciences leader staring down a CRM implementation or migration, assume the technology will work (because it will). The real differentiator is whether or not you anchor the change in optimized outcomes and wire governance and change management together from the start. Do that and you don’t just “upgrade your stack.” You build an engagement backbone that your people trust, your regulators respect and your AI strategy can finally stand on.
EPAM’s CRM vendor partnerships, life sciences industry expertise and seasoned change management practice combine to provide our life sciences clients with a seamless CRM implementation/migration experience. Get in touch with us to learn more.
